Lobo-Martins S, Debien V, Agostinetto E, Sirico M, et al. Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study. Clin Breast Cancer 2025 May 15:S1526-8209(25)00115.
PMID: 40483197